Effect of Sasa quelpaertensis Nakai extract consumption on cholesterol levels

Not Applicable

Completed

• Conditions: Endocrine, nutritional and metabolic disease

• Registration Number: KCT0000651
• Lead Sponsor: Jeju National University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 45

Inclusion Criteria

1) Voluntarily agree to participate and signed in informed consent form
2) Adults aged over 20 years
3) Plasma total cholesterol levels = 200mg/dl and < 250mgl/dl

Exclusion Criteria

1) Continuous consumption of drug or dietary supplement that affect lipid metabolism within 4 weeks before the first visit (statin, fibrate, beta-blocker, etc)
2) Following diseases:
? Myocardial infarction, stroke, uncontrolled hypertension (= 140/90mmHg)
? Diabetes
? Liver failure(AST, ALT rose more than 2.5 times the upper limit of normal)
? Renal impairment (Creatinine = 1.4mg/dl)
? Hyperthyroidism and hypothyroidism
? Malignant tumors
3) Familial hypercholesterolemia
4) BMI: <18kg/m2 and = 30kg/m2
5) Participation in another clinical trial within 4 weeks of first visit
6) Alcoholic
7) Any condition that the principal investigator belives may put the subjects at undue risk

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood lipid profile (total cholesterol, LDL-cholesterol, HDL-cholesterol, VLDL-cholesterol)

Secondary Outcome Measures

Name	Time	Method
Inflammatory biomarker (CRP, TNF-a)